Overview
- 18 inspections across 18 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-02-27.
At a glance
Inspections
18
Sites
18
Observations
0
Career since
May 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Octapharma Plasma Inc | 27 Feb 2020 | Biologics | |
| CSL Plasma Inc | 31 Oct 2019 | Biologics | |
| CSL Plasma Inc. | 25 Sep 2019 | Biologics | |
| Takeda Pharmaceutical Company d.b.a. BioLife Plasma Services LP | 29 Jun 2019 | Biologics | |
| Biomat USA, Inc. | 26 Jun 2019 | Biologics |
Sites inspected
Octapharma Plasma IncNorth Fort Myers, United States1 insp.
CSL Plasma IncIrondequoit, United States1 insp.
CSL Plasma Inc.Temple Terrace, United States1 insp.
Takeda Pharmaceutical Company d.b.a. BioLife Plasma Services LPKansas City, United States1 insp.
Biomat USA, Inc.Topeka, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Lauren M Lilly2 shared
Diane Hall2 shared
Samantha J Pinizzotto1 shared
Mizanne E Lewis1 shared
Lorayne A Mcguinness1 shared
Cody D Rickman1 shared
Mary E Baker-Brown1 shared
Hoimay Chan1 shared
Judy E Ciaraldi1 shared
Full investigator report
Get the verbatim findings behind Kanaeko R Ravenell's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site